Clinical Trial Update: Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

View source ↗

Summary

This completed clinical trial evaluated the relationship between hepatic fibrosis and cardiovascular risk in patients with non-alcoholic fatty liver disease usi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Clinique Pasteur | Conditions: NAFLD | Status: COMPLETED